SCIDOT-16. T2-WEIGHTED IMAGING MAY BE INDICATIVE OF DRUG DISTRIBUTION IN GLIOBLASTOMA PATIENTS

OBJECTIVES: Dogma suggests that for brain tumors, regions of enhancement on T1-weighted gadolinium contrast enhanced (T1Gd) magnetic resonance imaging (MRI) correlate with intravenously delivered drug distribution as enhancement indicates a compromised blood-brain barrier (BBB). However, poor respon...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Neuro Oncol
Egile Nagusiak: Jackson, Pamela, Kim, Minjee, Hawkins-Daarud, Andrea, Singleton, Kyle, Mohammad, Afroz, Burns, Terence, Parney, Ian, Hu, Leland, Kaufmann, Timothy, Elmquist, William, Sarkaria, Jann, Swanson, Kristin
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2019
Gaiak:
Abstracts from the 3rd Sno-Scidot Joint Conference on Therapeutic Delivery to the CNS
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6846504/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.1152
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak